|
1
|
Mohr A, Lyons M, Deedigan L, et al:
Mesenchymal stem cells expressing TRAIL lead to tumour growth
inhibition in an experimental lung cancer model. J Cell Mol Med.
12:2628–2643. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Donega V, van Velthoven CT, Nijboer CH,
Kavelaars A and Heijnen CJ: The endogenous regenerative capacity of
the damaged newborn brain: boosting neurogenesis with mesenchymal
stem cell treatment. J Cereb Blood Flow Metab. 33:625–634. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Matsuda K, Falkenberg KJ, Woods AA, Choi
YS, Morrison WA and Dilley RJ: Adipose-derived stem cells promote
angiogenesis and tissue formation for in vivo tissue engineering.
Tissue Eng Part A. 19:1327–1335. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zhang R, Liu Y, Yan K, et al:
Anti-inflammatory and immunomodulatory mechanisms of mesenchymal
stem cell transplantation in experimental traumatic brain injury. J
Neuroinflammation. 10:1062013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zhang YS, Wang Y, Wang L, et al: Labeling
human mesenchymal stem cells with gold nanocages for in vitro and
in vivo tracking by two-photon microscopy and photoacoustic
microscopy. Theranostics. 3:532–543. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hsu WT, Lin CH, Chiang BL, Jui HY, Wu KK
and Lee CM: Prostaglandin E2 potentiates mesenchymal stem
cell-induced IL-10+IFN-γ+CD4+
regulatory T cells to control transplant arteriosclerosis. J
Immunol. 190:2372–2380. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Panciani PP, Fontanella M, Tamagno I, et
al: Stem cells based therapy in high grade glioma: why the
intraventricular route should be preferred? J Neurosurg Sci.
56:221–229. 2012.PubMed/NCBI
|
|
8
|
Zhu X, Su D, Xuan S, et al: Gene therapy
of gastric cancer using LIGHT-secreting human umbilical cord
blood-derived mesenchymal stem cells. Gastric Cancer. 16:155–166.
2013. View Article : Google Scholar
|
|
9
|
Chen Q, Cheng P, Song N, et al: Antitumor
activity of placenta-derived mesenchymal stem cells producing
pigment epithelium-derived factor in a mouse melanoma model. Oncol
Lett. 4:413–418. 2012.
|
|
10
|
Belmar-Lopez C, Mendoza G, Oberg D, et al:
Tissue-derived mesenchymal stromal cells used as vehicles for
anti-tumor therapy exert different in vivo effects on migration
capacity and tumor growth. BMC Med. 11:1392013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Moriyama H, Moriyama M, Sawaragi K, Okura
H, Ichinose A, Matsuyama A and Hayakawa T: Tightly regulated and
homogeneous transgene expression in human adipose-derived
mesenchymal stem cells by lentivirus with tet-off system. PLoS One.
8:e662742013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Luetzkendorf J, Mueller LP, Mueller T,
Caysa H, Nerger K and Schmoll HJ: Growth inhibition of colorectal
carcinoma by lentiviral TRAIL-transgenic human mesenchymal stem
cells requires their substantial intratumoral presence. J Cell Mol
Med. 14:2292–2304. 2010. View Article : Google Scholar
|
|
13
|
Jaiswal PK, Singh V, Srivastava P and
Mittal RD: Association of IL-12, IL-18 variants and serum IL-18
with bladder cancer susceptibility in North Indian population.
Gene. 519:128–134. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kuppala MB, Syed SB, Bandaru S, Varre S,
Akka J and Mundulru HP: Immunotherapeutic approach for better
management of cancer - role of IL-18. Asian Pac J Cancer Prev.
13:5353–5361. 2012. View Article : Google Scholar
|
|
15
|
Ni J, Miller M, Stojanovic A, Garbi N and
Cerwenka A: Sustained effector function of IL-12/15/18-preactivated
NK cells against established tumors. J Exp Med. 209:2351–2365.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Shen Z, Seppänen H, Vainionpää S, Ye Y,
Wang S, Mustonen H and Puolakkainen P: IL10, IL11, IL18 are
differently expressed in CD14+ TAMS and play different
role in regulating the invasion of gastric cancer cells under
hypoxia. Cytokine. 59:352–357. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Crende O, Sabatino M, Valcárcel M, et al:
Metastatic lesions with and without interleukin-18-dependent genes
in advanced-stage melanoma patients. Am J Pathol. 183:69–82. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Taheri M, Hashemi M, Eskandari-Nasab E,
Fazaeli A, Arababi F, Bahrani-Zeidabadi M and Bahari G: Association
of -607 C/A polymorphism of IL-18 gene (rs1946518) with breast
cancer risk in Zahedan, Southeast Iran. Prague Med Rep.
113:217–222. 2012.PubMed/NCBI
|
|
19
|
Xu G, Jiang XD, Xu Y, et al:
Adenoviral-mediated interleukin-18 expression in mesenchymal stem
cells effectively suppresses the growth of glioma in rats. Cell
Biol Int. 33:466–474. 2009. View Article : Google Scholar
|
|
20
|
Srabović N, Mujagić Z,
Mujanović-Mustedanagić J, Muminović Z and Cickusić E: Interleukin
18 expression in the primary breast cancer tumour tissue. Med Glas
(Zenica). 8:109–115. 2011.
|
|
21
|
Yao L, Zhang Y, Chen K, Hu X and Xu LX:
Discovery of IL-18 as a novel secreted protein contributing to
doxorubicin resistance by comparative secretome analysis of MCF-7
and MCF-7/Dox. PLoS One. 6:e246842011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Fan X, Ye M, Xue B, Ke Y, Wong CK and Xie
Y: Human dendritic cells engineered to secrete interleukin-18
activate MAGE-A3-specific cytotoxic T lymphocytes in vitro. Immunol
Invest. 41:469–483. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Brennen WN, Denmeade SR and Isaacs JT:
Mesenchymal stem cells as a vector for the inflammatory prostate
microenvironment. Endocr Relat Cancer. 20:R269–R290. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Dwyer RM, Ryan J, Havelin RJ, et al:
Mesenchymal stem cell-mediated delivery of the sodium iodide
symporter supports radionuclide imaging and treatment of breast
cancer. Stem Cells. 29:1149–1157. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Matuskova M, Hlubinova K, Pastorakova A,
Hunakova L, Altanerova V, Altaner C and Kucerova L: HSV-tk
expressing mesenchymal stem cells exert bystander effect on human
glioblastoma cells. Cancer Lett. 290:58–67. 2010. View Article : Google Scholar
|
|
26
|
Ciavarella S, Grisendi G, Dominici M,
Tucci M, Brunetti O, Dammacco F and Silvestris F: In vitro
anti-myeloma activity of TRAIL-expressing adipose-derived
mesenchymal stem cells. Br J Haematol. 157:586–598. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Birnbaum T, Hildebrandt J, Nuebling G,
Sostak P and Straube A: Glioblastoma-dependent differentiation and
angiogenic potential of human mesenchymal stem cells in vitro. J
Neurooncol. 105:57–65. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Liang J, Huang W, Yu X, et al: Suicide
gene reveals the myocardial neovascularization role of mesenchymal
stem cells overexpressing CXCR4 (MSC(CXCR4)). PLoS One.
7:e461582012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Liu LN, Wang G, Hendricks K, Lee K,
Bohnlein E, Junker U and Mosca JD: Comparison of drug and
cell-based delivery: engineered adult mesenchymal stem cells
expressing soluble tumor necrosis factor receptor II prevent
arthritis in mouse and rat animal models. Stem Cells Transl Med.
2:362–375. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Jezierska-Drutel A, Rosenzweig SA and
Neumann CA: Role of oxidative stress and the microenvironment in
breast cancer development and progression. Adv Cancer Res.
119:107–125. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Creighton CJ, Gibbons DL and Kurie JM: The
role of epithelial-mesenchymal transition programming in invasion
and metastasis: a clinical perspective. Cancer Manag Res.
5:187–195. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Srivastava S, Pelloso D, Feng H, et al:
Effects of interleukin-18 on natural killer cells: costimulation of
activation through Fc receptors for immunoglobulin. Cancer Immunol
Immunother. 62:1073–1082. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Seo SH, Kim KS, Park SH, Suh YS, Kim SJ,
Jeun SS and Sung YC: The effects of mesenchymal stem cells injected
via different routes on modified IL-12-mediated antitumor activity.
Gene Ther. 18:488–495. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Wong JL, Berk E, Edwards RP and Kalinski
P: IL-18-primed helper NK cells collaborate with dendritic cells to
promote recruitment of effector CD8+ T cells to the
tumor microenvironment. Cancer Res. 73:4653–4662. 2013. View Article : Google Scholar : PubMed/NCBI
|
